MINNEAPOLIS, Dec. 10, 2015 /PRNewswire/ -- Evidentia Health, Inc. announced $1.2m of Series A financing led by Invenshure, LLC, a Minneapolis-based biotechnology venture catalyst and incubator. This financing adds Evidentia to Invenshure's portfolio of leading healthcare companies, including Exosite, Imbio, Flywheel, and OneOme. The partnership provides capital and resources to further develop Evidentia's innovative Enhanced Diagnostic Reports for radiology, pathology and other specialties, bringing patients and referring physicians context-relevant patient education, evidence-based research and novel communication tools embedded directly in personalized reports.
Jim Balabuszko-Reay, CEO of Evidentia Health Inc., said, "We are excited to be a part of the Invenshure family. This financing will allow us to expand our market reach, as well as develop new functionality to meet emerging market needs. We are also very interested in sharing technology and strategic growth plans with the other market-leading Invenshure portfolio companies." Mr Balabuszko-Reay went on to describe the projects Evidentia Health has implemented within Evidentia's founding investors institutions, the Mayo Clinic and the University of Minnesota, "Our work at these two top tier institutions was instrumental in our ability to build and integrate our technology that truly improves patient and physician engagement and helps radiologists communicate with their referring providers and patients in novel ways."
"This partnership expands Invenshure's portfolio of companies focusing on personalized medicine. We are building Evidentia to increase patient engagement through improved communication, giving all parties access to the right information at the right time. Through our platform, patients will gain a much improved understanding of the diagnoses and treatment plans they receive from their physician or healthcare provider," stated Troy Kopischke, Co-CEO of Invenshure."
About Evidentia Health:
Evidentia Health Inc. empowers radiologists and pathologists to better engage and communicate with their referring providers and patients. Launched in 2012, Evidentia co-developed and implemented their platform with their founding institutions, Mayo Clinic and University of Minnesota Physicians. Evidentia Enhanced Diagnostic Reporting platform transforms traditional text-based radiology and pathology reports into personalized reports with embedded images, specialist contact information, patient education, best evidence and critical result notification in a clean and readable format. Evidentia integrates with electronic health record systems and physician workflows by enhancing each diagnostic report with relevant imaging, clinical context, and patient education materials, while providing direct access to enhance reporting to referring physicians and patients for better care. For more information about Evidentia Health and the future of diagnostic reporting visit www.evidentiahealth.com
Invenshure is a venture catalyst that scours university research labs for novel and disruptive technologies ready for commercialization. Invenshure partners with top scientists, physicians, and researchers from the most trusted institutions in healthcare and technology. The company focuses on high-growth sectors including biotech, genomics, healthcare IT, diagnostics, cloud computing technologies, and wireless technologies. For more information, visit http://invenshure.com.
SOURCE Evidentia Health